| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FQI-2 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | -0.0083 | 0.9 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | JQ-1:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0046 | 0.9 |
| mRNA | JNK-9L | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.0071 | 0.9 |